These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10435495)

  • 21. Parkinson's disease and CYP2D6 polymorphism in Asian populations: A meta-analysis.
    Persad AS; Stedeford T; Tanaka S; Chen L; Banasik M
    Neuroepidemiology; 2003; 22(6):357-61. PubMed ID: 14557687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease.
    Santt O; Baranova H; Albuisson E; Bignon YJ; Lucotte G
    Eur J Neurol; 2004 Apr; 11(4):247-51. PubMed ID: 15061826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotyping of CYP2D6 in Parkinson's disease.
    Stefanović M; Topić E; Ivanisević AM; Relja M; Korsić M
    Clin Chem Lab Med; 2000 Sep; 38(9):929-34. PubMed ID: 11097352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.
    Harhangi BS; Oostra BA; Heutink P; van Duijn CM; Hofman A; Breteler MM
    Mov Disord; 2001 Mar; 16(2):290-3. PubMed ID: 11295783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of relation between genetic polymorphism of cytochrome P-450IID6 and sporadic idiopathic Parkinson's disease.
    Bordet R; Broly F; Destée A; Libersa C; Lafitte JJ
    Clin Neuropharmacol; 1996 Jun; 19(3):213-21. PubMed ID: 8726540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key.
    Mellick GD
    J Neural Transm Suppl; 2006; (70):159-65. PubMed ID: 17017524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2D6*4 polymorphism is not associated with Parkinson's disease and has no protective role against Alzheimer's disease in the Korean population.
    Woo SI; Kim JW; Seo HG; Park CH; Han SH; Kim SH; Kim KW; Jhoo JH; Woo JI
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):373-7. PubMed ID: 11442888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P450 enzymes and Parkinson's disease: the story so far.
    Riedl AG; Watts PM; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):212-20. PubMed ID: 9539332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2D6 polymorphism is not associated with essential tremor.
    Agúndez JA; Jiménez-Jiménez FJ; Tejeda R; Ledesma MC; Ortí-Pareja M; Gasalla T; Molina JA; Ruiz J; Coria F; Duarte J; Vázquez A; Ladero JM; Benítez J
    Eur Neurol; 1997; 38(2):99-104. PubMed ID: 9286632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease.
    Diederich N; Hilger C; Goetz CG; Keipes M; Hentges F; Vieregge P; Metz H
    Ann Neurol; 1996 Sep; 40(3):463-5. PubMed ID: 8797539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association between the debrisoquine hydroxylase gene polymorphism and the genetic susceptibility of Parkinson's disease].
    Tao E; Liu Z; Chen B; Pan X; Shao M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):281-3. PubMed ID: 9758873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis.
    McCann SJ; Pond SM; James KM; Le Couteur DG
    J Neurol Sci; 1997 Dec; 153(1):50-3. PubMed ID: 9455978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol dehydrogenase alleles in Parkinson's disease.
    Buervenich S; Sydow O; Carmine A; Zhang Z; Anvret M; Olson L
    Mov Disord; 2000 Sep; 15(5):813-8. PubMed ID: 11009184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):911-3. PubMed ID: 8057112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant debrisoquine hydroxylation genes in Parkinson's disease.
    Armstrong M; Daly AK; Cholerton S; Bateman DN; Idle JR
    Lancet; 1992 Apr; 339(8800):1017-8. PubMed ID: 1349052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
    Mann A; Miksys SL; Gaedigk A; Kish SJ; Mash DC; Tyndale RF
    Neurobiol Aging; 2012 Sep; 33(9):2160-71. PubMed ID: 21958961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
    Bandmann O; Vaughan J; Holmans P; Marsden CD; Wood NW
    Lancet; 1997 Oct; 350(9085):1136-9. PubMed ID: 9343502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease.
    Bordet R; Broly F; Destee A; Libersa C
    Clin Neuropharmacol; 1994 Oct; 17(5):484-8. PubMed ID: 9316701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.